Beta-blockers and ACE inhibitors: New data, old myths

Gary S. Francis, William R Lewis, William Parmley, C. Wayne Weart

Research output: Contribution to journalArticle

2 Scopus citations


Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

Original languageEnglish (US)
Pages (from-to)62-84
Number of pages23
JournalPatient Care
Issue number13
StatePublished - 2000

ASJC Scopus subject areas

  • Leadership and Management

Fingerprint Dive into the research topics of 'Beta-blockers and ACE inhibitors: New data, old myths'. Together they form a unique fingerprint.

  • Cite this

    Francis, G. S., Lewis, W. R., Parmley, W., & Weart, C. W. (2000). Beta-blockers and ACE inhibitors: New data, old myths. Patient Care, 34(13), 62-84.